Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers.
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
The next generation of exoskeletons: lighter, cheaper devices are in the works.
A palliative care hotline for multiple sclerosis: A pilot feasibility study.
Multiple sclerosis.
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.
Serum level of interleukin-6 in Chinese patients with multiple sclerosis.
A touch of MS: Therapeutic mislabeling.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Mast cells: an expanding pathophysiological role from allergy to other disorders.
A practical guide to the treatment of neuromyelitis optica.
FDA approves injectable drug to treat opioid-dependent patients
[Sexuality of men with neurologic disorders].
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Coping strategies and mood profiles in patients with multiple sclerosis.
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Immune modulating peptides for the treatment and suppression of multiple sclerosis.
SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains.
Segway use in individuals with multiple sclerosis.
Prolongation of survival of rat cardiac allografts by T cell vaccination.

Pages